PATENT CLAIM ANALYSIS

Application Number: 16380769
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-08
Patent Classification: ["568", "744000"]

Abstract:
The present invention is directed to inhibitors of tyrosinase, pharmaceutical compositions comprising such tyrosinase inhibitors, and methods of making and using the same. Specifically, included in the present invention are compositions of matter comprised of at least one 2,4-dihydroxybenzene analog, which inhibit the activity of tyrosinase and which inhibit the overproduction of melanin.

Claim (Index 54):
A method for inhibiting the production of melanin comprising administering to a subject in need thereof a composition comprising the compound of  claim 48 .

Metadata:
- Claim Count in Document: 23.0
- Percentile: 100.0
- Lexical Diversity: 1.59459
- Patent Class: 568.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15620395', '14750873', '13722394', '12506497', '14154013']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7950017514326202
- 35 USC 102 Novelty (BERT): 0.6270496894617141
- Combined Prediction Score: 0.7782065452355296
- Mean Citation Score: 583.102192
- Max Citation Score: 612.5373
- Similarity Product: 519.5682814514995

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test